Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Regul Toxicol Pharmacol. 2018 Apr 17;96:1–17. doi: 10.1016/j.yrtph.2018.04.014

Table 5.

Common components of an IST protocol (IATA = Integrated Approaches to Testing and Assessment; AOP = Adverse Outcome Pathways)

Introduction
  • Describe the major toxicological endpoint being assessed

  • Outline the general hazard assessment framework, including how a series of toxicological effects or mechanisms are related to one or more endpoints

  • Provide citations to any applicable AOPs or IATAs used

In silico methodologies and models
  • Identify toxicological effects or mechanisms that might realistically be predicted

  • Define what in silico methodologies are appropriate to use

  • Specify additional considerations as to what constitutes an acceptable model

  • Discuss issues to be considered as part of any read-across analysis

Experimental data
  • Define specific study types and result(s) relevant to each toxicological effect or mechanism

  • Define and justify the relevance of the information to the assessment of the toxicological endpoint (defined in the hazard assessment framework)

  • Define specific factors to consider when assessing the results and documenting the reliability of any available data or reference specific test guideline(s)

  • Identify sources of data that may be considered

Toxicological effects or mechanisms assessment and reliability scores
  • Describe how each toxicological effect or mechanism assessment may be generated from available experimental data and/or in silico prediction(s)

  • Define additional items to consider as part of an expert review

  • Discuss any endpoint specific issues to consider as part of the reliability score

Toxicological endpoint assessment and confidence
  • Describe the toxicological endpoints that will be used as part of the hazard assessment framework

  • Describe the rules or principles for determining each endpoint assessment, based on the associated effect/mechanisms or other endpoints

  • Define the rules or principles for determining each toxicological endpoint confidence, based on the relevance and reliability (from associated effects/mechanisms) or confidence (from associated endpoints)

  • Identify points to consider as part of any expert review

Reporting
  • Define a format for a report of the results, expert review and conclusions

Other considerations
  • Case studies